Wood Dale, IL — PHC Corporation of North America (PHCNA), supplier of the PHCbi brand of preservation and growth products in North America and Latin America, has launched a next-generation high heat CO₂ incubator that offers laboratories new industry-leading contamination protection for valuable research samples. The incubator, model MCO-171AICUVD-PA, includes antimicrobial properties and smart design features that support precision cell culture research while streamlining laboratory operations and helping labs reduce their environmental impact.

The advanced contamination protection features in the incubator include inCu-saFe chamber material, which combines the germicidal properties of elemental copper with the corrosion and discoloration resistance of stainless steel. It features a new long-lasting SafeCell UV-LED germicidal bulb and an optional 11-hour high heat (180°C) sterilization cycle, which allows for the decontamination of the chamber and interior parts of the incubator at the industry gold-standard temperature. PHCbi is the only brand to offer this combination of contamination protection features.

This high heat cell culture incubator is designed to help reduce a lab’s environmental impact by eliminating the need for consumables like HEPA filters and UV mercury-based bulbs, both of which must be replaced throughout the lifespan of other models on the market. By reducing downtime due to contamination, the incubator can also help streamline laboratory operations. Its stackable design and improved insulation offer added flexibility and a space-saving solution for busy lab environments — allowing one incubator in a stack to be decontaminated while neighboring incubators continue to operate at set point.

Derek Sokolowski, PHCNA Cell Culture Product Manager, said, “At PHC, our goal is to continuously improve the technology of cell culture incubation with innovative features and smart design that solves practical challenges that researchers face. We are excited to introduce this next-generation incubator that allows scientists to conduct their cell culture research in an accurate and precise manner while saving time and energy, so they can focus on their work instead of contamination issues.”

PHC Corporation of North America (PHCNA) is a part of PHC Group, a global company dedicated to improving health through digital and precision technology.

For more information about the PHCbi brand MCO-171AICUVD-PA incubator, please visit https://www.phchd.com/us/biomedical/incubators/CO2incubators/mco-171aicuvd-pa.

About PHC Corporation of North America

PHC Corporation of North America, located in Wood Dale, IL, is a leader in laboratory equipment for the biopharmaceutical, life sciences, academic, healthcare and government markets. Product lines under the PHCbi brand include the space saving and energy efficient VIP® ECO SMART and TwinGuard® ultra-low temperature freezers, cryogenic and biomedical freezers, pharmacy and high-performance refrigerators, cell culture CO₂ and multigas incubators, Drosophila/plant growth chambers, and cell and gene therapy solutions. PHC Corporation of North America is a subsidiary of PHC Holdings Corporation, Tokyo, Japan, which is a global healthcare company that develops, manufactures, sells, and services solutions across diabetes management, healthcare solutions, diagnostics and life sciences.

About the Biomedical Division of PHC Corporation

Established in 1969, PHC Corporation is a Japanese subsidiary of PHC Holdings Corporation (TSE 6523), a global healthcare company that develops, manufactures, sells, and services solutions across diabetes management, healthcare solutions, life sciences and diagnostics. The Biomedical Division supports the life sciences industry helping researchers and healthcare providers in around 110 countries and regions through its laboratory and equipment and services including CO₂ incubators and ultra-low temperature freezers.
www.phchd.com/global/phc

About PHC Holdings Corporation

PHC Holdings Corporation (TSE 6523) is a global healthcare company with a mission of contributing to the health of society through healthcare solutions that have a positive impact and improve the lives of people. Its subsidiaries (referred to collectively as PHC Group) include PHC Corporation, Ascensia Diabetes Care Holdings AG, Epredia Holdings Ltd., LSI Medience Corporation, Wemex Corporation, and Mediford Corporation. Together, these companies develop, manufacture, sell and service solutions across diabetes management, healthcare solutions, diagnostics and life sciences. PHC Group’s consolidated net sales in FY2023 were JPY 353.9 billion with global distribution of products and services in more than 125 countries and regions.
www.phchd.com/us/biomedical